Book on Doctolib
← Back to articles
Retinal Diseases Written and reviewed by Dr Julien Gozlan, ophthalmic surgeon · 12/11/2026
A doctor and family members in consultation around a family tree tracing cases of hereditary AMD

Hereditary AMD: What is the risk when a parent is affected?

Dr Julien Gozlan
Dr Julien Gozlan
Ophthalmic Surgeon · Cataract & Retina Specialist · Paris 16

Hereditary AMD is one of the most common concerns raised during consultations: "my mother has AMD—will I get it too?" The term hereditary AMD is actually a shortcut, because the disease is not passed on like a simple genetic trait. Having an affected parent does genuinely increase the risk, but it is not inevitable. AMD is a multifactorial disease: genes matter, age matters, and the environment matters just as much. Here is what we know today, and above all what you can do in practical terms.

Hereditary AMD: what exactly are we talking about?

AMD (age-related macular degeneration) affects the macula, the area of the retina responsible for sharp central vision. When several members of the same family are affected, the condition is often referred to as hereditary AMD. In reality, what is passed on is not the disease itself but a predisposition. This genetic susceptibility only manifests when it encounters other factors: aging, smoking, diet, and sun exposure. That is the key difference from a classic genetic disease.

Does hereditary AMD truly exist?

No. A hereditary disease in the strict sense follows Mendelian inheritance: a single mutated gene is enough, and the risk of transmission can be calculated precisely from one generation to the next. This is the case for certain forms of retinitis pigmentosa, for example. AMD does not work that way. It results from the combined effect of many common genetic variations, each of small effect, together with age and lifestyle. No one "passes on" the disease to their children. At most, a degree of susceptibility is transmitted: it is in this sense, and this sense only, that the expression hereditary AMD should be understood.

What is the risk in the case of hereditary AMD?

The familial risk—what the term hereditary AMD concretely refers to—is real and well documented. Having an affected first-degree relative—father, mother, brother or sister—multiplies the risk compared with the general population: the order of magnitude is several-fold. But this finding must be properly understood:

To understand all the factors involved, read our article on the causes of AMD.

The genes behind AMD: CFH and ARMS2/HTRA1

Research has identified two regions of the genome that are particularly involved: the complement factor H gene (CFH), which regulates inflammation, and the ARMS2/HTRA1 region. Carrying risk variants in these regions increases the likelihood of developing the disease. However, none of these variants is sufficient on its own: many carriers will never become ill, and some affected patients do not carry them. This is proof that genetics does not write the story alone: what we call hereditary AMD is a predisposition, not a sentence.

Should you get a genetic test for hereditary AMD?

No. Genetic testing for hereditary AMD is not recommended in routine clinical practice, and this point deserves a clear explanation:

Outside research protocols, this test therefore has no place today.

Smoking and heredity: the most dangerous combination

Smoking is the most powerful modifiable risk factor for this disease. And it does not simply add to the genetic predisposition: it interacts with it. In a person carrying risk variants, smoking dramatically multiplies the likelihood of developing the disease. In other words, when there is a hereditary AMD predisposition, quitting smoking—or never starting—is the single most effective decision you can make for your eyes.

Hereditary AMD: how to reduce your risk?

When facing a hereditary AMD predisposition, you cannot choose your genes, but you can act on everything else:

Hereditary AMD: what monitoring is needed when a parent is affected?

In the case of hereditary AMD—that is, a family history of the disease—the practical approach is straightforward. Plan a baseline fundus examination around the age of 50–55, or earlier if a symptom appears: decreased vision, wavy straight lines, or a central spot. The monitoring frequency is then tailored by your ophthalmologist. An OCT scan often complements the examination to analyze the macula in detail. Also learn to use the Amsler grid: this simple test, performed at home one eye at a time, helps detect line distortion at an early stage.

FAQ: Hereditary AMD

My mother has AMD: will I necessarily get it?

No. Your risk is higher than that of the general population, but most children of patients will never develop a severe form. Hereditary AMD refers to a predisposition, not a destiny.

At what age should I have a first fundus exam?

Around age 50–55 in the absence of symptoms, to have a baseline examination. Earlier if you notice decreased vision, distorted lines, or a spot in the center of your visual field.

Is genetic testing useful in cases of hereditary AMD?

No, it is not recommended in routine practice. It does not change monitoring or treatment, and its results cannot individually predict who will develop the disease.

Hereditary AMD: will I pass it on to my children?

You do not pass on the disease itself, but possibly a degree of predisposition. Your children will benefit from the same advice as you: no smoking, a healthy lifestyle, and a fundus exam around age 50–55.

What can I do now to reduce my risk?

Do not smoke, eat green vegetables and fish, protect your eyes from the sun, watch your weight and blood pressure. And consult promptly if you experience any new visual symptoms.

When should you see Dr Julien Gozlan?

If one of your parents has AMD, a screening consultation gives you a clear picture: fundus examination, OCT angiography if needed, and personalized prevention advice. Consult promptly if you experience distorted lines, a central spot, or decreased vision. Dr Julien Gozlan, an ophthalmic surgeon specializing in retinal conditions in Paris 16, provides this screening and follow-up for patients with a hereditary AMD predisposition.

📍 Consultation at Cabinet Ophtalmologique Paris - Auteuil

Dr Julien Gozlan welcomes patients at Cabinet Ophtalmologique Paris - Auteuil for an AMD screening assessment in cases of family history: fundus examination, macular imaging, and prevention advice tailored to your situation.

Book an appointment

Further reading

References & medical sources

  1. Klaver CC, Wolfs RC, Assink JJ, et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol. 1998. doi:10.1001/archopht.116.12.1646 — View on PubMed
  2. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005. doi:10.1126/science.1109557 — View on PubMed
  3. Fritsche LG, Igl W, Bailey JN, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016. doi:10.1038/ng.3448 — View on PubMed
  4. Schmidt S, Hauser MA, Scott WK, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet. 2006. doi:10.1086/503822 — View on PubMed
  5. Jabbarpoor Bonyadi MH, Yaseri M, Bonyadi M, et al. Association of combined cigarette smoking and ARMS2/LOC387715 A69S polymorphisms with age-related macular degeneration: A meta-analysis. Ophthalmic Genet. 2017. doi:10.1080/13816810.2016.1237664 — View on PubMed
  6. Flaxel CJ, Adelman RA, Bailey ST, et al. Age-Related Macular Degeneration Preferred Practice Pattern®. Ophthalmology. 2020. doi:10.1016/j.ophtha.2019.09.024 — View on PubMed
Chat on WhatsApp
Dr Julien Gozlan
Ophthalmologist
Hello, connecting you to Dr Julien Gozlan.